Durataf 25 mg tablet

Durataf 25 mg Tablet; Price, Pack Sizes, and Bulk Ordering

Get HIV Treatment carries Durataf 25 mg tablet for resellers and stockists looking to source this compound. Pricing details are available directly on the product listing page. Buyers placing bulk orders can check current per-bottle rates before confirming quantities.

Product Information

Durataf 25 mg tablet contains Tenofovir Alafenamide as its active ingredient. Each tablet delivers 25 mg of Tenofovir Alafenamide in solid oral tablet form. The manufacturer for this product is Dr. Reddy Laboratories.

Durataf 25 mg belongs to the nucleotide reverse transcriptase inhibitor drug class. These are antiretroviral agents used in the treatment of Human Immunodeficiency Virus infection.

What This Product Treats

Durataf 25 mg tablet is used for the treatment of Human Immunodeficiency Virus type 1 infection in adults. It is taken as part of combination antiretroviral therapy. This means it is stocked alongside other antiretroviral agents by resellers supplying clinics, pharmacies, and treatment programs.

Demand for this drug category remains stable. Buyers reorder consistently.

Available Strengths and Pack Sizes

The active ingredient Tenofovir Alafenamide is available in the following strength in Durataf:

• Durataf 25 mg tablet

Pack size information is available on the product listing at Get HIV Treatment. Bottle count per carton should be verified at checkout. Buyers placing a bulk order should confirm current stock availability and per-bottle pricing at the time of ordering.

How It Works

Tenofovir Alafenamide is a nucleotide reverse transcriptase inhibitor. After you take it, the body converts it into its working form inside the cells. Once active, it blocks the reverse transcriptase enzyme. This is the enzyme that Human Immunodeficiency Virus uses to copy its genetic material into DNA inside the host cell.

By blocking this step, the compound interrupts viral replication early on. The Human Immunodeficiency Virus cannot produce new copies of itself at the same rate. This is the core mechanism that makes Tenofovir Alafenamide effective within combination antiretroviral regimens.

Side Effect

The side effect of Durataf 25 mg is typical of the nucleotide reverse transcriptase inhibitor drug class. Buyers stocking this product should be aware of the following reported side effects associated with Tenofovir Alafenamide:

• Nausea
• Headache
• Fatigue
• Diarrhea
• Abdominal discomfort
• Decreased bone mineral density with long-term use
• Kidney function changes, less commonly reported compared to older Tenofovir compounds

Tenofovir Alafenamide generally has a more favorable kidney and bone side effect profile than earlier Tenofovir formulations. This is a relevant product characteristic for buyers supplying markets where long-term treatment adherence matters.

Shelf Life and Storage Requirements

Durataf 25 mg tablet should be stored at room temperature, below 30 degrees Celsius. Keep the tablets away from direct sunlight and store them somewhere dry with low humidity. The original packaging should remain sealed until the point of dispensing.

Standard shelf life for tablets in this drug class is typically 24 months from the date of manufacture. Buyers should check the expiry date printed on each carton when receiving stock. Proper storage protects product integrity for stockists managing large quantities.

Why Buyers Choose Durataf 25 mg Tablet

Tenofovir Alafenamide is well established and widely prescribed in combination antiretroviral therapy programs. The demand pipeline is consistent. Its improved tolerability compared to older Tenofovir formulations means it holds a strong position in formularies and treatment lists.

Dr. Reddy Laboratories produces this tablet to meet the quality standards expected in international antiretroviral supply chains. That consistency supports buyer confidence when placing ongoing bulk orders.